newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering

NovaBay Pharmaceuticals, Inc. (NYSE:NBY) (the "Company" or "NovaBay"), today announced the pricing of its underwritten public offering of 3,200,380 shares of common stock (or pre-funded warrants in lieu thereof),